論文・総説 - 原田　浩之

21. Otsuru M, Yamakawa N, Kirita T, Yamada SI, Kurita H, Kugimoto T, Harada H, Hasegawa T, Akashi M, Takeshita A, Uzawa N, Umeda M, Yanamoto S, Yamada T. Efficacy and safety of molecularly targeted agents and immune checkpoint inhibitors for unresectable or recurrent/metastatic oral cancer in Japan. J Dent Sci. 2024.07; 19 (3): 1628-1637. ( PubMed, DOI )

22. Ibi H, Takahashi K, Harada H, Watabe T, Podyma-Inoue KA. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis. Biochem Biophys Res Commun. 2024.06; 714 149965. ( PubMed, DOI )

23. Suenaga M, Yamauchi S, Morikawa R, Noji R, Kano Y, Tokunaga M, Kinugasa Y. Chemotherapy and COVID-19 Vaccination in Patients With Gastrointestinal Cancer in vivo. 2024.05; 38 (3): 1278-1284. ( DOI )

24. Yamaguchi K, Okumura T, Oikawa Y, Nakagawa K, Yoshimi K, Harada H, Tohara H. Effect of oral intake initiation-establishment interval on hospital stay after oral cancer surgery Oral Diseases. 2024.05;

25. Kuroshima T, Kitagawa Y, Sato J, Watanabe S, Asaka T, Abe T, Harada H, Hirata K, Kuge Y. Maximum standardized uptake value in 11C-methionine positron emission tomography may predict the prognosis of patients with oral squamous cell carcinoma. Odontology. 2024.05; ( PubMed, DOI )

26. Iwasaki T, Harazono Y, Fukawa Y, Kaida A, Kayamori K, Sasaki Y, Harada H, Yoda T. Retrospective analysis of odontogenic myxoma and odontogenic myxofibroma in the oral and maxillofacial region: a fibrous tissue-related differentiation. Br J Oral Maxillofac Surg. 2024.02; ( PubMed, DOI )

27. Tokizaki S, Podyma-Inoue KA, Matsumoto T, Takahashi K, Kobayashi M, Ibi H, Uchida S, Iwabuchi S, Harada H, Hashimoto S, Miyazono K, Shirouzu M, Watabe T. Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks Cancer Science. 2024.01; 115 (1): 211-226. ( DOI )

28. Takahiro Naito, Rika Noji, Takuma Kugimoto, Takeshi Kuroshima, Hirofumi Tomioka, Shun Fujiwara, Mitsukuni Suenaga, Hiroyuki Harada, Yoshihito Kano. The Efficacy of Immunotherapy and Clinical Utility of Comprehensive Genomic Profiling in Adenoid Cystic Carcinoma of Head and Neck. Medicina (Kaunas). 2023.12; 59 (12): 2111. ( PubMed, DOI )

29. Takeda D, Kurita H, Kashima Y, Hasegawa T, Miyakoshi M, Yamada SI, Yamamura Y, Soutome S.. Is withdrawl of antiresorptive agents necessary before and after tooth extraction? A systematic review. Clin Oral Invest. 2023.12; 28 (1): 38. ( PubMed, DOI )

30. Shiori Tokizaki, Katarzyna A Podyma-Inoue, Takehisa Matsumoto, Kazuki Takahashi, Miho Kobayashi, Haruka Ibi, Shizuka Uchida, Sadahiro Iwabuchi, Hiroyuki Harada, Shinichi Hashimoto, Kohei Miyazono, Mikako Shirouzu, Tetsuro Watabe. Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks. Cancer Sci. 2023.11; ( PubMed, DOI )

31. Tomioka H, Nishii H, Oikawa Y, Kugimoto T, Kuroshima T, Hirai H, Kayamori K, Kaida A, Miura M, Harada H. Clinicopathological analysis of 134 patients with squamous cell carcinoma of the mandibular gingiva Heliyon. 2023.11; 10 (1): e23120. ( PubMed, DOI )

32. Kinoshita N, Hirai H, Fukawa Y, Yamagata Y, Kashima Y, Sato M, Ikeda T, Harada H. A case of dentinogenic ghost cell tumor of the mandible with a review of the literature J Oral Maxillofac Surg Med Pathol. 2023.11; 35 (6): 545-549. ( DOI )

33. Takuma Kugimoto, Naoto Nishii, Yu Oikawa, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Yasuyuki Michi, Kou Kayamori, Junichiro Sakamoto, Joe Iwanaga, R Shane Tubbs, Tohru Ikeda, Masahiko Miura, Hiroyuki Harada. Invasion of the bucco-mandibular space by oral squamous cell carcinoma: histopathological analysis of invasion pattern. Front Oncol. 2023.10; 13 1168376. ( PubMed, DOI )

34. Sato J, Kodaira M, Harada H, Iguchi H, Yoshida T, Shibata H, Diagnosis and treatment of bone metastasis: comprehensive guideline (the 2nd Edition) developing group. Efficacy and safety of bone management agents administered at 12 weeks vs. 4 weeks in patients with bone metastases: A systematic review. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2023.10; 10781552231203720. ( PubMed, DOI )

35. Okuyama K, Fukushima H, Naruse T, Yanamoto S. Cell-in-cell structure in cancer: evading strategies from anti-cancer therapies Front Oncol. 2023.09; 13 1248097. ( PubMed, DOI )

36. Akihiro Homma, Mizuo Ando, Nobuhiro Hanai, Hiroyuki Harada, Yoshitaka Honma, Tomonori Kanda, Satoshi Kano, Daisuke Kawakita, Naomi Kiyota, Yoshiyuki Kizawa, Masahiro Nakagawa, Takenori Ogawa, Hirotaka Shinomiya, Takeshi Shinozaki, Motoyuki Suzuki, Tetsuya Tsuji, Koichi Yasuda, Sadamoto Zenda, Takeshi Kodaira, Tadaaki Kirita, Ken-Ichi Nibu. Summary of Japanese clinical practice guidelines for head and neck cancer - 2022 update edited by the Japan society for head and neck cancer. Auris Nasus Larynx. 2023.07; S0385-8146 (23): 00140-2. ( PubMed, DOI )

37. Akaike Y, Morita K, Sakamoto K, Tsushima F, Kayamori K, Maruta N, Yamazaki K, Anzai E, Tonouchi E, Harada H, Ikeda T, Yoda T.. 口腔扁平苔癬様病変に伴う海綿状態の機械学習を使用した自動検出 Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2023.07; 35 (4): 368-374. ( DOI 医中誌 )

38. Pissacha Daroonpan, Ryo Ouchi, Chenyang Zhang, Shigenori Nagai, Naoto Nishii, Yoshihisa Kashima, Fumihiko Tsushima, Hiroyuki Harada, Miwako Hamagaki, Tohru Ikeda, Jun Aida, Ruchadaporn Kaomongkolgit, Miyuki Azuma. Personal immune profiles: Diversity and prognostic value for oral tongue squamous cell carcinoma evaluated by comprehensive immune parameter analyses with multiplex immunofluorescence. Oral Oncol. 2023.06; 143 106458. ( PubMed, DOI )

39. Ito K, Tokura S, Takazawa I, Yoshida N, Nakanishi T, Akiyama K, Onuma Y, Adachi T, Harada H, Nojima H, Miura M, Yoshimura R, Kabasawa Y. Clinical investigation of use of Episil® oral solution in oral mucositis during radiotherapy for head and neck cancer. Heliyon. 2023.05; 9 (6): e15869. ( PubMed, DOI )

40. Okuyama K, Naruse T, Yanamoto S. Tumor microenvironmental modification by the current target therapy for head and neck squamous cell carcinoma J Exp Clin Cancer Res. 2023.05; 42 (1): 114. ( PubMed, DOI )